Active Ingredient: RISEDRONATE SODIUM
Proprietary Name: RISEDRONATE SODIUM
Dosage Form; Route of Administration: TABLET, DELAYED RELEASE; ORAL
Strength: 35MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A203217
Product Number: 001
Approval Date: May 18, 2015
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA
Marketing Status:
Prescription
Patent and Exclusivity Information